Menu
In a world increasingly affected by fatigue, cognitive decline, and chronic pain, science offers a new hope: RP-25, an innovative formulation with therapeutic potential in conditions linked to mitochondrial dysfunction, including fibromyalgia.
RP-25 is a synergistic combination of:
Chaga extract (25% beta-glucans)
Coenzyme Q10 (CoQ10)
Alpha-lipoic acid (ALA)
Dihydroquercetin + essential micronutrients
This formula was designed to protect mitochondria, support ATP production, and reduce oxidative stress.
Researchers used neuronal SH-SY5Y cells and advanced metabolomic techniques (NMR and UHPLC-HRMS) to assess:
Cell viability
ATP levels
Mitochondrial membrane potential
Reactive oxygen species (ROS) levels
+400% increase in ATP – Sign of enhanced mitochondrial energy output
Stabilization of mitochondrial membrane potential – Better mitochondrial health
Significant reduction of ROS – Clear antioxidant effect
Boosted amino acid and neurotransmitter metabolism – Tyrosine, glutamate, glycine, proline
Fibromyalgia is characterized by mitochondrial dysfunction, inflammation, and energy depletion. RP-25 could serve as an adjuvant therapy by:
Supporting mitochondrial bioenergetics
Regulating oxidative stress
Enhancing neurotransmitter biosynthesis
Also promising for:
Chronic fatigue
Post-viral syndromes
Cognitive decline
RP-25 demonstrates a scientifically validated potential to optimize mitochondrial function, increase cellular energy, and reduce oxidative stress. Though current results are from in vitro studies, they open new directions for future clinical research in chronic and neurodegenerative disorders.
D’Elia, M. et al. (2025). Impact of a Formulation Containing Chaga Extract, Coenzyme Q10, and Alpha-Lipoic Acid on Mitochondrial Dysfunction and Oxidative Stress: NMR Metabolomic Insights into Cellular Energy. Antioxidants, 14(753). doi.org/10.3390/antiox14060753